Dr. Emily Christie, Canada
Hyperkalemia in the early post renal transplant period

Mr. Erlend J. Egeland, Norway
Determination of tacrolimus concentration and protein expression of P-glycoprotein in single human renal core biopsies

Ms. Marte Theie Gustavsen, Norway
High-dose fish oil supplementation increase tacrolimus exposure in stable renal transplant recipients

Dr. Akhilesh Kumar Jaiswal, India
Inter-individual variability of tacrolimus tough level may be due to differential p-glycoprotein expression on PBMCs in renal transplant recipient

Miss Alicia Molina, Spain
Safety of induction immunosuppression in kidney transplantation: Focus on 1-year hospitalizations for infection and development of post-transplant neoplasia

Dr. Juan Carlos Ruiz, Spain
A retrospective study on effectiveness and safety of the novel once-daily melt-dose tacrolimus in a spanish cohort of stable kidney transplant recipients converted from once or twice-daily formulations: Reconoce study

Dr. David Tollerud, United States
The ratio of CTLA4 to perforin and granzyme b as a potential biomarker of tolerance in chimeric renal transplant patients

Dr. Julien Vionnet, Switzerland
Eculizumab and intravenous immunoglobulins for the treatment of acute antibody-mediated rejection after lung and liver transplantation

Miss Teresa Vazquez, Spain
Analysis of CCR4high CD4+ in kidney graft blood after steroid withdrawal: A prospective, randomized, controlled, parallel group study. Preliminary results